Eficacia de los bloqueadores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos
- 1 January 2000
- journal article
- abstracts
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 53 (3) , 422-439
- https://doi.org/10.1016/s0300-8932(00)75107-4
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Platelet GPIIb-IIIa blockersThe Lancet, 1999
- Acute Coronary SyndromesCirculation, 1998
- Toward a New Frontier in Myocardial Reperfusion TherapyCirculation, 1998
- Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery diseaseEuropean Heart Journal, 1996
- Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.Circulation, 1994
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Ligand Binding to GPIIb-IIIa: A Status ReportSeminars in Thrombosis and Hemostasis, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992